Similarly, IFN-γ promoted a significant increase in the conversion of TCR-stimulated CD4+CD25− T cells to suppressive CD4+CD25+FOXP3+ T cells in patients with Guillain-Barré syndrome or myasthenia gravis [69, 70]. This evidence concerns the gene IFNG and Guillain-Barre syndrome.